Toxocariasis is a worldwide human helminthiasis, especially seen in temperate and tropical climate regions around the world. The diagnosis of this disease is performed on the basis of clinical symptoms and laboratory findings. Albendazole is one of the treatment choices for toxocariasis, with a currently recommended regimen of 10 mg/kg/day in two doses (400 mg twice daily) for 5 days. However, there is no precise consensus about the duration of the treatment. In this article, we report a case of toxocariasis; the patient visited our infectious disease polyclinic with complaints of long-term itching and urticarial skin lesions that were resistant to routine treatment and that recurred. Then, recurrent disease was resolved and skin lesions were diminished after prolonged albendazole therapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5152/tpd.2015.3285 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Microsporidiosis in Patients with Autoimmune Diseases Undergoing Monoclonal Antibody Associated Therapy.
Mycopathologia
January 2025
Sorbonne Université, Inserm U1135, Centre d'Immunologie et de Maladies Infectieuses (Cimi-Paris), AP-HP, Hôpital Saint-Antoine, Service de Parasitologie-Mycologie, 184 rue Faubourg Saint Antoine, 175012, Paris, France.
We present Enterocytozoon bieneusi infection in four patients with autoimmune diseases undergoing prolonged monoclonal antibody therapies. Two patients suffered from inflammatory bowel disease and received anti-TNF therapies, whereas two other patients suffered from systemic lupus erythematosus with renal involvement and received anti-CD20 or anti-BLyS protein therapies. Three out of four patients consulted for diarrhea with abdominal pain without intestinal inflammation or bleeding at the time of sampling.
View Article and Find Full Text PDFStrongyloides hyperinfection and disseminated infections are usually associated with immunosuppression; these severe manifestations occur in a minority of cases. The use of immunosuppressants such as corticosteroids and Baricitinib for treating COVID-19 pneumonia can be responsible for patients' immunosuppression and cause Strongyloides hyperinfection syndrome. The chance increases when the patient belongs to countries or regions where chronic infection with Strongyloides is more prevalent.
View Article and Find Full Text PDFEchiNam: multicenter retrospective study on the experience, challenges, and pitfalls in the diagnosis and treatment of alveolar echinococcosis in Belgium.
Eur J Clin Microbiol Infect Dis
November 2024
Department of Infectious Diseases, CHU UCL Namur (Site Godinne), Université catholique de Louvain, Avenue Dr Gaston Thérasse 1, Yvoir, 5530, Belgium.
Objectives: The aim of this retrospective study was to collect epidemiological, clinical, laboratory, imaging, management, and follow-up data on cases of alveolar echinococcosis (AE) diagnosed and/or followed up within the Namur Hospital Network (NHN) in order to gather information on the challenges, pitfalls, and overall experience in the diagnosis and treatment of AE.
Methods: EchiNam was a multicenter retrospective study. Patients diagnosed and/or treated for probable or confirmed AE in the NHN between 2002 and 2023 were included in the study.
Treatment approach in bilateral pulmonary hydatid cysts: analysis of 107 consecutive cases.
Indian J Thorac Cardiovasc Surg
November 2024
Medical Faculty, Department of Cardiovascular Surgery, Üsküdar University, Istanbul, Turkey.
Objective: Bilateral pulmonary involvement is observed in around 14% of cases of pulmonary hydatid cysts and the treatment can be challenging. This study evaluates the clinical characteristics and treatment strategies used for cases of bilateral pulmonary hydatid cysts.
Materials And Methods: A retrospective examination was conducted on 107 consecutive cases of bilateral pulmonary hydatid cysts treated in our clinic between January 2003 and December 2023.
Alveolar echinococcosis.
Tidsskr Nor Laegeforen
September 2024
Nasjonal referansefunksjon for serologisk parasittdiagnostikk, Universitetssykehuset i Nord-Norge.
Article Synopsis
- Alveolar echinococcosis is a serious parasitic disease caused by the Echinococcus multilocularis larva, primarily affecting the liver and presenting with tumor-like growths.
- Although mainland Norway is generally free from this infection, it can occasionally be introduced from areas where the disease is more common.
- The review covers the life cycle of the parasite, symptoms, diagnosis and treatment options, including surgery and medication, and includes case studies of two patients affected by the disease.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!